Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +1.52% slid 3.10% to $123.92 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.02% falling 1.94% to 4,700.58 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.34% falling 1.07% to 36,407.11. This was the stock's fourth consecutive day of losses. Edwards Lifesciences Corp. closed $7.81 below its 52-week high ($131.73), which the company reached on December 30th.
The stock underperformed when compared to some of its competitors Wednesday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT +2.36% fell 0.36% to $106.01, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +3.77% fell 1.35% to $43.05, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +2.79% fell 0.69% to $229.97. Trading volume (2.2 M) remained 222,050 below its 50-day average volume of 2.4 M.